Rheumatoid arthritis (RA) is currently diagnosed and treated when an individual presents
with signs and symptoms of inflammatory arthritis (IA) as well as other features, such as …

The results from ongoing natural history and prevention trials in RA should further inform
several critical issues in RA prevention including identification and enrolment of individuals …

Rheumatoid arthritis (RA) is a chronic autoimmune disease considered as a multistep
process spanning from the interaction of genetic (eg, shared epitope or non-HLA loci) …

Background Rheumatoid arthritis (RA) is an autoimmune disease characterized by
symmetrical peripheral polyarthritis in the hands and/or feet, leading to long-term disability if …

Background Despite growing interest, there is no guidance or consensus on how to conduct
clinical trials and observational studies in populations at risk of rheumatoid arthritis (RA) …

Rheumatoid arthritis (RA) is the most common systemic inflammatory rheumatic disease. It is
associated with significant burden at the patient and societal level. Extensive efforts have …

Early treatment is associated with improved outcomes in patients with rheumatoid arthritis
(RA), suggesting that a'window of opportunity', in which the disease is most susceptible to …

Rheumatoid arthritis (RA) is an autoimmune disease characterized by joint inflammation,
which affects approximately 1% of the population. The benefit of early recognition and …

Rheumatoid arthritis (RA) affects 1% of the population worldwide and is characterised by
persistent inflammation and joint damage. It has repeatedly been observed that early …

Established and emerging data demonstrate that a'preclinical'period of disease precedes
the onset of clinical rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE), as …